DICE Therapeutics, Inc.
DICE Therapeutics, Inc. (DICE) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 48 transactions totaling $238.1M, demonstrating a bearish sentiment with -$6.1M in net insider flow. The most recent transaction on Aug 9, 2023 involved a transaction of 147,497 shares valued at $0.
DICE Insider Activity Summary
Who Is Buying DICE Stock?
No significant insider buying has been recorded for DICE in the recent period.
Who Is Selling DICE Stock?
No significant insider selling has been recorded for DICE in the recent period.
Is DICE Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DICE is bearish with an Insider Alignment Score of 49/100 and a net flow of -$6.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
DICE Frequently Asked Questions
Understanding DICE Insider Activity
Insider trading at DICE Therapeutics, Inc. (DICE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading DICE stock, having executed 48 transactions in the past 90 days. The most active insider is Ventures Ii, Lp Northpond (Executive), who has made 2 transactions totaling $115.9M.
Related Tools
Track DICE Therapeutics, Inc. Insider Activity
Get notified when executives and directors at DICE file new Form 4 transactions